Senescent Cell Clearance
Clearing the 'zombie' cells that age your body.
Senescent cells stop dividing but refuse to die, building up in tissues and leaking inflammatory signals that accelerate aging. Senolytic protocols aim to selectively remove them — one of the most promising levers for extending healthspan.
The science
As we age, more cells enter senescence and secrete a mix of inflammatory molecules known as the SASP, which damages neighboring healthy tissue and drives stiffness, frailty, and chronic disease. Clearing even a fraction of these cells has rejuvenated tissues in preclinical models.
Senolytic compounds are designed to push senescent cells into self-destruction while sparing healthy ones. The investigational cohorts EverLife Lab tracks study dosing schedules, target tissues, and the biomarkers that signal a real reduction in senescent burden.
Why it matters
- Targets chronic, age-related inflammation at its source
- Linked to improved tissue function in preclinical studies
- Intermittent dosing schedules under active investigation
- Tracked with inflammatory and senescence biomarkers
Frequently asked questions
What are senolytics?
Senolytics are agents designed to selectively eliminate senescent 'zombie' cells that accumulate with age and drive inflammation and tissue decline.
Why do senescent cells matter for aging?
They secrete inflammatory signals that damage surrounding tissue, which makes their accumulation a recognized hallmark of aging.
How do members access these trials?
EverLife Lab members get priority pre-registration to vetted senolytic cohorts operated by independent partner labs.
Get priority access to vetted cohorts
EverLife Lab members receive priority pre-registration to investigational longevity cohorts operated by independent partner labs, matched to their tier. Protocol names, partner labs, and registration details are reserved for members.